|
Time |
Topic |
|
09.00 A.M. to 09.05 A.M. |
Welcome - Dr. Pankaj
Shah |
|
09.05 A.M. to 09.35 A.M. |
Clinical Research:
Performance
Chairpersons: Dr. Kirti
Patel and Dr. Suresh
Sanchetee |
|
|
- Setting up
clinical research
infrastructure at
site – Dr. Bina
Naik – 15 minutes
- Capacity
building at ICON
Clinical Trial sites
– Dr.– 15
minutes
|
|
09.35 A.M. to 11.00 A.M. |
Clinical Research:
Planning and
interpretation
Chairpersons: Dr. Pankaj
Shah and Dr. JK Singh |
|
|
- Adoptive
clinical trial
design – Dr. Ms.
Marie-Paul Derde
Head of Veeda
Biometrics from
Brussels, Belgium–
20 minutes
- Pitfalls in
current large
multicentre trials
for sequenced
targeted therapy
- Prof. Ray Powles –
40 minutes
|
|
11.00 A.M. to 11.15 AM |
COFFEE BREAK |
|
11.15 A.M. to 13.15 P.M. |
Clinical Research:
Hypothesis:
Chairpersons: Dr. SN
Shukla and ---- |
|
|
1. Best Hypothesis
Presentations: 45
minutes
2. Molecular Biology;
From lab to bedside:
Dr. Rajkumar 40 minutes
3. Focus on PK/PD
studies: Dr. RK
Goyal 15 minutes
4. Working with caBIG
TBD 20 minutes |
|
13.15 P.M. to 14.00 PM |
LUNCH BREAK |
|
|
Disease
specific sessions: |
|
14.00 P.M. to 14.40 PM |
Colo -rectal cancer:
Chairpersons: Dr.
Ghanshyam Biswas
Moderator: Dr. Abhishek
Joshi |
|
|
1. MAS in colo-rectal:
Dr. Sanjiv
Haribhakti
2. Beyond 5-FU in
metastatic colorectal
cancer: Dr. K.
Govindbabu |
|
14.40 P.M. to 15.30 PM |
Pediatric Oncology:
Chairpersons: Dr. PA
Kurkure and Dr. Deepa
Trivedi |
|
|
a. Pediatric ALL:
Burning issues in
Management in India
– Dr. Shreepad Banavali
b. Advances and
Controversies in Ewing’s
/PNET –Dr. Gauri
Kapoor |
|
15.30 A.M. to 15.45 AM |
COFFEE BREAK |
|
15.45 P.M. to 17.00 PM |
Recent advances:
Chairpersons: Dr. DC
Doval
Moderator: Dr. Purvish
Parikh |
|
|
Newer molecules in
pipeline:
Off Label use of
drugs in oncology:
Oncologist’s view:
Dr. AK Vaid
Off Label use of
drugs in oncology:
Regulator’s view:
Dr. RT Chacko
Moderator’s Comments
Dr. PMP |
|
17.00 P.M. to 17.30 PM |
EC Meeting |
|
18.00 P.M. to 19.00 PM |
Satellite Symposium |
|
|
Update on NSCLC:
Dr. Vasanthi: Biology of
NSCLC
Dr. Hemant Malhotra:
VEGF/EGFR inhibition in
NSCLC
Dr. Future directions in
NSCLC |
|
19.00 P.M. to 20.00 PM |
Inauguration Compeering:
Dr. Deepa Trivedi |
|
|
Welcome: Dr. Bharat
Parikh
Guest of Honour: Dr.
Pankaj Shah
Inauguration and
Lecture: Dr. Bakul
Dholakiya
ICON Convener: Dr.
Purvish Parikh
Thanks: Dr. Chirag Desai |
|
20.00 P.M. to 22.00 PM |
BANQUET/DINNER |
|
Time |
Topic |
|
08.30 A.M. to 09.00 A.M. |
GB Meeting |
|
09.00 A.M. to 09.40 A.M. |
Best Thesis
(Chairs: Dr. Prakash
Chitalkar) |
|
09.40 A.M. to 10.40 A.M. |
Head and Neck:
Surgical Vs Non surgical
organ/function
preservation in Head and
Neck Cancer: |
|
|
Chairpersons and
moderator: Dr. Deepak
Parikh
i. Surgical approach to
organ preservation in
advanced H&N. - Dr. Anil
D’Cruz – 20 minutes
ii. Non-surgical
approaches: ICT Vs Conc
CT/RT –20 minutes Dr.
Mahmut Ozsahin –
Lausanne, Switzerland
iii. Future of
non-surgical approaches
- Dr. Sanjay Jain – 25
minutes
iv. How can India/ICON
take a lead in these
trials??? 05 minutes TBD
v. Audience
participation 10 minutes |
|
10.40 A.M. to 10.55 AM |
COFFEE BREAK |
|
10.55 A.M. to 11.40 A.M. |
BREST CANCER |
|
|
Chairpersons and
moderator: TBD
1. Taxane Resistance in
MBC: Dr. Alexander – BMS
20 minutes
2. Tyrosine Kinase
inhibitors in MBC: 20
minutes
Dr. Bhawna Sirohi – 20
minutes |
|
11.40 A.M. to 12.20 P.M. |
Ovarian Cancer:
Single agents or
combination in recurrent
ovarian cancer: debate |
|
|
Chairpersons: TBD
Moderator: Dr. GS
Bhattacharya
1. Sequential single
agents –– 15 minutes
2. Combination – 15
minutes
3. Moderator’s comments
and possible role ICON
can play 8 minutes
4. Audience
participation 7 minutes |
|
12.20 P.M. to 12.40 A.M. |
Cancer screening
recommendations for
common cancers: |
|
|
a. Cervix
b. Oral cancer
c. Breast |
|
12.40 P.M. to 13.00 A.M. |
One Decade of ICON:
Taking stalk and looking
ahead Dr. P. Parikh |
|
13.00 P.M. to 13.40 PM |
LUNCH BREAK |